Monosomy-3 Alters the Expression Profile of the Glucose Transporters GLUT1-3 in Uveal Melanoma

Monosomy-3 in uveal melanoma (UM) cells increases the risk of fatal metastases. The gene encoding the low-affinity glucose transporter GLUT2 resides on chromosome 3q26.2. Here, we analyzed the expression of the glucose transporters GLUT1, GLUT2, and GLUT3 with regard to the histological and clinical factors by performing immunohistochemistry on the primary tumors of n = 33 UM patients. UMs with monosomy-3 exhibited a 57% lower immunoreactivity for GLUT2 and a 1.8×-fold higher ratio of GLUT1 to total GLUT1-3. The combined levels of GLUT1-3 proteins were reduced in the irradiated but not the non-irradiated tumors with monosomy-3. GLUT3 expression was stronger in the irradiated samples with disomy-3 versus monosomy-3, but the ratio of the GLUT3 isoform to total GLUT1-3 did not differ with regard to the monosomy-3 status in the irradiated or non-irradiated subgroups. Systemic metastases were associated with the presence of monosomy-3 in the primary and circulating tumor cells as well as a higher GLUT1 ratio. Upregulation of the high-affinity glucose transporter GLUT1 possibly as a compensation for the low-affinity isoform GLUT2 may be enhancing the basal glucose uptake in the UM cells with monosomy-3. Prevention of hyperglycemia might, therefore, be a valuable approach to delay the lethal UM metastases.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:21

Enthalten in:

International journal of molecular sciences - 21(2020), 24 vom: 08. Dez.

Sprache:

Englisch

Beteiligte Personen:

Maaßen, Tjorge [VerfasserIn]
Vardanyan, Siranush [VerfasserIn]
Brosig, Anton [VerfasserIn]
Merz, Hartmut [VerfasserIn]
Ranjbar, Mahdy [VerfasserIn]
Kakkassery, Vinodh [VerfasserIn]
Grisanti, Salvatore [VerfasserIn]
Tura, Aysegül [VerfasserIn]

Links:

Volltext

Themen:

Biomarkers, Tumor
GLUT1
GLUT2
GLUT3
Glucose Transport Proteins, Facilitative
Glucose transport
Journal Article
Monosomy-3
Uveal melanoma

Anmerkungen:

Date Completed 04.03.2021

Date Revised 04.03.2021

published: Electronic

Citation Status MEDLINE

doi:

10.3390/ijms21249345

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM318678071